{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:15:20Z","timestamp":1792124120610,"version":"4.4.0"},"reference-count":140,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T00:00:00Z","timestamp":1466380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The aberrant activity of Wnt signaling is an early step in the transformation of normal intestinal cells to malignant tissue, leading to more aggressive tumors, and eventually metastases. In colorectal cancer (CRC), metastasis accounts for about 90% of patient deaths, representing the most lethal event during the course of the disease and is directly linked to patient survival, critically limiting successful therapy. This review focuses on our studies of the metastasis-inducing gene S100A4, which we identified as transcriptional target of \u03b2-catenin. S100A4 increased migration and invasion in vitro and metastasis in mice. In patient CRC samples, high S100A4 levels predict metastasis and reduced patient survival. Our results link pathways important for tumor progression and metastasis: the Wnt signaling pathway and S100A4, which regulates motility and invasiveness. S100A4 suppression by interdicting Wnt signaling has potential for therapeutic intervention. As proof of principle, we applied S100A4 shRNA systemically and prevented metastasis in mice. Furthermore, we identified small molecule inhibitors from high-throughput screens of pharmacologically active compounds employing an S100A4 promoter-driven reporter. Best hits act, as least in part, via intervening in the Wnt pathway and restricted metastasis in mouse models. We currently translate our findings on restricting S100A4-driven metastasis into clinical practice. The repositioned FDA-approved drug niclosamide, targeting Wnt signaling, is being tested in a prospective phase II clinical trial for treatment of CRC patients. Our assay for circulating S100A4 transcripts in patient blood is used to monitor treatment success.<\/jats:p>","DOI":"10.3390\/cancers8060059","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T12:51:28Z","timestamp":1466427088000},"page":"59","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0036-5283","authenticated-orcid":false,"given":"Mathias","family":"Dahlmann","sequence":"first","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9 University Medicine, Berlin and Max-Delbr\u00fcck-Center for Molecular Medicine, Robert-R\u00f6ssle-Str. 10, 13125 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Kobelt","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9 University Medicine, Berlin and Max-Delbr\u00fcck-Center for Molecular Medicine, Robert-R\u00f6ssle-Str. 10, 13125 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Walther","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9 University Medicine, Berlin and Max-Delbr\u00fcck-Center for Molecular Medicine, Robert-R\u00f6ssle-Str. 10, 13125 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giridhar","family":"Mudduluru","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9 University Medicine, Berlin and Max-Delbr\u00fcck-Center for Molecular Medicine, Robert-R\u00f6ssle-Str. 10, 13125 Berlin, Germany"},{"name":"German Cancer Consortium, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-282X","authenticated-orcid":false,"given":"Ulrike","family":"Stein","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9 University Medicine, Berlin and Max-Delbr\u00fcck-Center for Molecular Medicine, Robert-R\u00f6ssle-Str. 10, 13125 Berlin, Germany"},{"name":"German Cancer Consortium, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/35094067","article-title":"APC, signal transduction and genetic instability in colorectal cancer","volume":"1","author":"Fodde","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-540-46091-6_7","article-title":"Clinical, biological, and molecular aspects of metastasis in colorectal cancer","volume":"176","author":"Stein","year":"2007","journal-title":"Recent Results Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.biocel.2009.08.001","article-title":"Colon cancer metastasis: MACC1 and Met as metastatic pacemakers","volume":"41","author":"Arlt","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canep.2009.05.001","article-title":"A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans","volume":"33","author":"Scholtka","year":"2009","journal-title":"Cancer Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/cncr.22983","article-title":"Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer","volume":"110","author":"Mudduluru","year":"2007","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4253\/wjge.v8.i5.252","article-title":"New era of colorectal cancer screening","volume":"8","author":"Cummings","year":"2016","journal-title":"World J. Gastrointest. Endosc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cellsig.2013.11.032","article-title":"Wnt signaling in adult intestinal stem cells and cancer","volume":"26","author":"Krausova","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ceb.2013.01.004","article-title":"Wnt signaling in stem and cancer stem cells","volume":"25","author":"Holland","year":"2013","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"C511","DOI":"10.1152\/ajpcell.00117.2015","article-title":"Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms","volume":"309","author":"Novellasdemunt","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386035-4.00002-1","article-title":"New insights into the mechanism of Wnt signaling pathway activation","volume":"291","author":"Kikuchi","year":"2011","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1582-4934.2007.00201.x","article-title":"The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology","volume":"12","author":"Nakamura","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng0404-320","article-title":"Shutting down Wnt signal-activated cancer","volume":"36","author":"Taketo","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-008-9156-4","article-title":"The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression","volume":"25","author":"Vincan","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Kinzler","year":"1996","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/79859","article-title":"Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin\/TCF signalling","volume":"26","author":"Liu","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arcmed.2015.01.001","article-title":"Expression and mutation pattern of \u03b2-catenin and adenomatous polyposis coli in colorectal cancer patients","volume":"46","author":"Triki","year":"2015","journal-title":"Arch. Med. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"a002915","DOI":"10.1101\/cshperspect.a002915","article-title":"Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling","volume":"2","author":"Heuberger","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.3.7.1086","article-title":"Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family","volume":"3","author":"Ebralidze","year":"1989","journal-title":"Genes Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.R500017200","article-title":"S100A4, a mediator of metastasis","volume":"281","author":"Garrett","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","article-title":"A soluble protein characteristic of the nervous system","volume":"19","author":"Moore","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1051\/gse:2008013","article-title":"Chromosomal mapping, differential origin and evolution of the S100 gene family","volume":"40","author":"Shang","year":"2008","journal-title":"Genet. Sel. Evol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ceca.2012.11.006","article-title":"Evolution of the S100 family of calcium sensor proteins","volume":"53","author":"Zimmer","year":"2013","journal-title":"Cell Calcium"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1023\/A:1009212521172","article-title":"New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family","volume":"11","author":"Heizmann","year":"1998","journal-title":"Biometals"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/pro.267","article-title":"Design of high-affinity S100-target hybrid proteins","volume":"18","author":"Rezvanpour","year":"2009","journal-title":"Protein Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20060195","article-title":"Calcium-dependent and -independent interactions of the S100 protein family","volume":"396","author":"Shaw","year":"2006","journal-title":"Biochem. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbamcr.2004.09.002","article-title":"Target selectivity in EF-hand calcium binding proteins","volume":"1742","author":"Bhattacharya","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0968-0004(96)80167-8","article-title":"The S100 family of EF-hand calcium-binding proteins: functions and pathology","volume":"21","author":"Heizmann","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","article-title":"S100 proteins in cancer","volume":"15","author":"Bresnick","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2006.08.041","article-title":"The metastasis-associated gene S100A4 is a novel target of beta-catenin\/T-cell factor signaling in colon cancer","volume":"131","author":"Stein","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/art.22042","article-title":"Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products","volume":"54","author":"Yammani","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/ar2301","article-title":"Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta\/bone morphogenic protein signalling","volume":"9","author":"Hopwood","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cfg.428","article-title":"Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy","volume":"5","author":"Knudsen","year":"2004","journal-title":"Comp. Funct. Genomics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2007.03.027","article-title":"S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes","volume":"75","author":"Schneider","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbrc.2006.02.161","article-title":"Parietal endoderm secreted S100A4 promotes early cardiomyogenesis in embryoid bodies","volume":"343","author":"Stary","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2353\/ajpath.2010.090526","article-title":"S100A4 and metastasis: a small actor playing many roles","volume":"176","author":"Boye","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_39","first-page":"27","article-title":"Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer","volume":"1","author":"Sagara","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-05-1580","article-title":"Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer","volume":"12","author":"Martin","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_41","first-page":"2547","article-title":"Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma","volume":"29","author":"Tsuna","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s11605-009-0978-4","article-title":"S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma","volume":"13","author":"Ikenaga","year":"2009","journal-title":"J. Gastrointest. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.5301\/jbm.5000054","article-title":"Clinicopathological and prognostic value of S100A4 expression in gastric cancer: A meta-analysis","volume":"29","author":"Ling","year":"2014","journal-title":"Int. J. Biol. Markers"},{"key":"ref_44","first-page":"140","article-title":"ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma","volume":"63","author":"Hernan","year":"2003","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1111\/j.1742-4658.2009.07274.x","article-title":"Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein","volume":"276","author":"Sumer","year":"2009","journal-title":"FEBS J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1541-7786.MCR-09-0102","article-title":"Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion","volume":"7","author":"Kim","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1074\/jbc.M803997200","article-title":"Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4\/metastasin","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jcm5040041","article-title":"Signal Transduction Pathways of EMT Induced by TGF-\u03b2, SHH, and WNT and Their Crosstalks","volume":"5","author":"Zhang","year":"2016","journal-title":"J. Clin. Med."},{"key":"ref_49","first-page":"F563","article-title":"Early role of Fsp1 in epithelial-mesenchymal transformation","volume":"273","author":"Okada","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1074\/mcp.M113.029587","article-title":"Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target","volume":"12","author":"Rasanen","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5009\/gnl.2014.8.1.94","article-title":"Differential expression of E-cadherin, \u03b2-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers","volume":"8","author":"Sung","year":"2014","journal-title":"Gut Liver"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xu, X., Su, B., Xie, C., Wei, S., Zhou, Y., Liu, H., Dai, W., Cheng, P., Wang, F., and Xu, X. (2014). Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096441"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1746-1596-8-99","article-title":"Combined aberrant expression of E-cadherin and S100A4, but not \u03b2-catenin is associated with disease-free survival and overall survival in colorectal cancer patients","volume":"8","author":"Lee","year":"2013","journal-title":"Diagn. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.22916","article-title":"Heterogeneous expression of Wnt\/beta-catenin target genes within colorectal cancer","volume":"121","author":"Hlubek","year":"2007","journal-title":"Int. J. cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1472-6807-13-31","article-title":"Structure of the S100A4\/myosin-IIA complex","volume":"13","author":"Ramagopal","year":"2013","journal-title":"BMC Struct. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/bioa.26133","article-title":"The heavy chain has its day: regulation of myosin-II assembly","volume":"3","author":"Dulyaninova","year":"2013","journal-title":"Bioarchitecture"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00249-004-0428-x","article-title":"Interaction of metastasis-inducing S100A4 protein in vivo by fluorescence lifetime imaging microscopy","volume":"34","author":"Zhang","year":"2005","journal-title":"Eur. Biophys. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/15384101.2014.995495","article-title":"S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells","volume":"14","author":"Jaiswal","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4020-6191-2_5","article-title":"Pathologies involving the S100 proteins and RAGE","volume":"45","author":"Heizmann","year":"2007","journal-title":"Subcell. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/156652407783220688","article-title":"RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins","volume":"7","author":"Donato","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00018-013-1400-7","article-title":"Joining S100 proteins and migration: for better or for worse, in sickness and in health","volume":"71","author":"Gross","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbrc.2004.02.135","article-title":"S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells","volume":"316","author":"Hsieh","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1570-9639(02)00447-8","article-title":"Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton","volume":"1600","author":"Belot","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1038\/sj.onc.1207720","article-title":"Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity","volume":"23","author":"Grigorian","year":"2004","journal-title":"Oncogene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1128\/MCB.26.9.3625-3638.2006","article-title":"Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein","volume":"26","author":"Kiryushko","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.18632\/oncotarget.1908","article-title":"RAGE mediates S100A4-induced cell motility via MAPK\/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis","volume":"5","author":"Dahlmann","year":"2014","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/thy.2014.0257","article-title":"RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells","volume":"25","author":"Medapati","year":"2015","journal-title":"Thyroid"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jcmm.12808","article-title":"Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells","volume":"20","author":"Herwig","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/jnci\/djh275","article-title":"Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging","volume":"96","author":"Maggard","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1746-1596-8-181","article-title":"Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"Diagn. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.ejca.2010.07.013","article-title":"Nuclear S100A4 is a novel prognostic marker in colorectal cancer","volume":"46","author":"Boye","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00384-012-1469-8","article-title":"Overexpression of protein S100A4 is independently associated with overall survival in stage C colonic cancer but only in cytoplasm at the advancing tumour front","volume":"27","author":"Kho","year":"2012","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jmoldx.2010.10.002","article-title":"Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients","volume":"13","author":"Stein","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Stein, U., Burock, S., Herrmann, P., Wendler, I., Niederstrasser, M., Wernecke, K.-D., and Schlag, P.M. (2012). Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049249"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3748\/wjg.v21.i1.333","article-title":"Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker","volume":"21","author":"Burock","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.1889","article-title":"MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis","volume":"15","author":"Stein","year":"2009","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/14728222.2013.815727","article-title":"MACC1\u2014a novel target for solid cancers","volume":"17","author":"Stein","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13277-014-2736-9","article-title":"MACC1 overexpression and survival in solid tumors: a meta-analysis","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12885-015-1150-z","article-title":"Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: A retrospective cohort study","volume":"15","author":"Koelzer","year":"2015","journal-title":"BMC Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10585-015-9732-3","article-title":"Molecular targets and pathways involved in liver metastasis of colorectal cancer","volume":"32","author":"Weidle","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1078-0432.CCR-1168-3","article-title":"Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients","volume":"10","author":"Wong","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"22112","DOI":"10.1038\/srep22112","article-title":"Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer","volume":"6","author":"Barbazan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_83","first-page":"5490","article-title":"Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme","volume":"56","author":"Maelandsmo","year":"1996","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3892\/or.2011.1598","article-title":"Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells","volume":"27","author":"Huang","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"783","DOI":"10.18632\/oncotarget.572","article-title":"Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation","volume":"3","author":"Dahlmann","year":"2012","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"20833","DOI":"10.1074\/jbc.M412653200","article-title":"Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation","volume":"280","author":"Semov","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1177\/147323001103900420","article-title":"Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma","volume":"39","author":"Feng","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1073\/pnas.1109493108","article-title":"VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization","volume":"108","author":"Sugimoto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","first-page":"1495","article-title":"S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF","volume":"17","author":"Jia","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7150\/ijms.8128","article-title":"Activation of the PI3K\/Akt\/mTOR\/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells","volume":"11","author":"Wang","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.2930240119","article-title":"Sulindac for polyposis of the colon","volume":"24","author":"Waddell","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ajg.2011.38","article-title":"Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort","volume":"106","author":"Ruder","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_93","first-page":"2452","article-title":"Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction","volume":"57","author":"Piazza","year":"1997","journal-title":"Cancer Res."},{"key":"ref_94","first-page":"1679","article-title":"Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression","volume":"3","author":"Elder","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.bjc.6601505","article-title":"Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines","volume":"90","author":"Boon","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-11-0559","article-title":"A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and \u03b2-catenin transcriptional activity","volume":"5","author":"Whitt","year":"2012","journal-title":"Cancer Prev. Res. (Phila)."},{"key":"ref_97","first-page":"2909","article-title":"Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels","volume":"57","author":"Piazza","year":"1997","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/carcin\/17.8.1757","article-title":"Sulindac suppresses tumorigenesis in the Min mouse","volume":"17","author":"Levy","year":"1996","journal-title":"Carcinogenesis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4615-4149-3_5","article-title":"Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis","volume":"470","author":"Stoner","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2004.061432","article-title":"Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study","volume":"55","author":"Arber","year":"2006","journal-title":"Gut"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1593\/neo.101172","article-title":"Intervening in \u03b2-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis","volume":"13","author":"Stein","year":"2011","journal-title":"Neoplasia"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.redox.2015.08.012","article-title":"NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties","volume":"6","author":"Kashfi","year":"2015","journal-title":"Redox Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1568026023394317","article-title":"Application of high-throughput, molecular-targeted screening to anticancer drug discovery","volume":"2","author":"Shoemaker","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jnci\/djr190","article-title":"Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer","volume":"103","author":"Sack","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jnci\/djr221","article-title":"Niclosamide: An established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors","volume":"103","author":"Helfman","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1091\/mbc.e10-09-0739","article-title":"S100A4-induced cell motility and metastasis is restricted by the Wnt\/\u03b2-catenin pathway inhibitor calcimycin in colon cancer cells","volume":"22","author":"Sack","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.bi.45.070176.002441","article-title":"Biological applications of ionophores","volume":"45","author":"Pressman","year":"1976","journal-title":"Annu. Rev. Biochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/elps.1150150163","article-title":"Modulation of mts1 expression in mouse and human normal and tumor cells","volume":"15","author":"Grigorian","year":"1994","journal-title":"Electrophoresis"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1242\/jcs.03256","article-title":"Protein-kinase-C-mediated beta-catenin phosphorylation negatively regulates the Wnt\/beta-catenin pathway","volume":"119","author":"Gwak","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/2211016a0","article-title":"Mechanism of action of reagents that uncouple oxidative phosphorylation","volume":"221","author":"Weinbach","year":"1969","journal-title":"Nature"},{"key":"ref_111","unstructured":"(2015). The Selection and Use of Essential Medicines. World Health Organ. Tech. Rep. Ser., vii\u2013xv, 1\u2013546."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2016.03.002","article-title":"Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets","volume":"26","author":"Mudduluru","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi9009677","article-title":"The anti-helminthic niclosamide inhibits Wnt\/Frizzled1 signaling","volume":"48","author":"Chen","year":"2009","journal-title":"Biochemistry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"G293","DOI":"10.1152\/ajpgi.00005.2010","article-title":"Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach","volume":"299","author":"Chen","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cellsig.2016.02.011","article-title":"A crosstalk between TGF-\u03b2\/Smad3 and Wnt\/\u03b2-catenin pathways promotes vascular smooth muscle cell proliferation","volume":"28","author":"DiRenzo","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Lu, W., Lin, C., Roberts, M.J., Waud, W.R., Piazza, G.A., and Li, Y. (2011). Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/\u03b2-catenin pathway. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0029290"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-10-3978","article-title":"Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations","volume":"71","author":"Osada","year":"2011","journal-title":"Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2147\/OTT.S50065","article-title":"Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway","volume":"6","author":"Tomizawa","year":"2013","journal-title":"Onco. Targets. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.fertnstert.2014.01.017","article-title":"Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth","volume":"101","author":"Ono","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1535-7163.MCT-13-0555","article-title":"Effect of niclosamide on basal-like breast cancers","volume":"13","author":"Arend","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.04.005","article-title":"Inhibition of Wnt\/\u03b2-catenin pathway by niclosamide: a therapeutic target for ovarian cancer","volume":"134","author":"Arend","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/onc.2014.277","article-title":"WNT7A\/\u03b2-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer","volume":"34","author":"King","year":"2015","journal-title":"Oncogene"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Satoh, K., Zhang, L., Zhang, Y., Chelluri, R., Boufraqech, M., Nilubol, N., Patel, D., Shen, M., and Kebebew, E. (2016). Identification of niclosamide as a novel anticancer agent for adrenocortical carcinoma. Clin. Cancer Res.","DOI":"10.1158\/1078-0432.CCR-15-2256"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: A new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5732\/cjc.011.10290","article-title":"Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells","volume":"31","author":"Pan","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/1568009615666150629132157","article-title":"The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways","volume":"15","author":"Liao","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Balgi, A.D., Fonseca, B.D., Donohue, E., Tsang, T.C.F., Lajoie, P., Proud, C.G., Nabi, I.R., and Roberge, M. (2009). Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007124"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"17530","DOI":"10.1074\/jbc.M112.359638","article-title":"Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling","volume":"287","author":"Fonseca","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"35769","DOI":"10.1074\/jbc.M113.511212","article-title":"Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/1535-7163.MCT-13-0095","article-title":"Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Li, R., You, S., Hu, Z., Chen, Z.G., Sica, G.L., Khuri, F.R., Curran, W.J., Shin, D.M., and Deng, X. (2013). Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074670"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ml100146z","article-title":"Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway","volume":"1","author":"Ren","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/1078-0432.CCR-12-2895","article-title":"Anticancer effects of niclosamide in human glioblastoma","volume":"19","author":"Wieland","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bmcl.2013.01.101","article-title":"Small molecule modulators of Wnt\/\u03b2-catenin signaling","volume":"23","author":"Mook","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1016\/j.bmc.2015.07.001","article-title":"Structure-activity studies of Wnt\/\u03b2-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure","volume":"23","author":"Mook","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/IGC.0000000000000506","article-title":"Niclosamide Analogs for Treatment of Ovarian Cancer","volume":"25","author":"Arend","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1535-7163.MCT-14-1038","article-title":"Targeting Wnts at the source\u2014New mechanisms, new biomarkers, new drugs","volume":"14","author":"Madan","year":"2015","journal-title":"Mol. Cancer Ther."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/8\/6\/59\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:25:45Z","timestamp":1760210745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/8\/6\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,20]]},"references-count":140,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["cancers8060059"],"URL":"https:\/\/doi.org\/10.3390\/cancers8060059","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,20]]}}}